Nick Cross joins Trust board
The Oxford Trust is delighted to announce the appointment of Nick Cross to its Board.
Nick is probably most well-known as the co-founder of Milton Park, alongside his university friend and Trust supporter Ian Laing.
Nick is also a major contributor to the region’s innovation ecosystem, both as an entrepreneur and investor. He was a co-founder and Chairman of Immunocore (2008) and a significant investor in and non-executive director of Avidex (2000–2006). His previous ventures have included Adaptimmune, Oxford Asymmetry Ltd (now part of Evotec), Oxford Semiconductor Ltd (now part of Toshiba), Doctors.net (now part of M3 Corporation) and Oxxon (now part of Oxford Biomedica).
John Boyle, our Chair of Trustees, says, “We are honoured that Nick has agreed to join the Board and excited for the opportunity his experience and knowledge will bring to our strategic direction going forward.”
Nick says, “ I am honoured and delighted to join the Board.
Ever since I returned from the US in the mid-1980s I have been both a beneficiary of and a supporter of The Oxford Trust. From the first stirring of the emergence of knowledge-based businesses, the Woods have been both a role model and a key enabler. I read Scintilla and attended the Innovation Club at the Science and Technology Enterprise Project (STEP) Centre on Osney Mead. Martin broke the ground for the first high tech development at Milton Park. I became a start-up “junkie” and am still at it.
I have been delighted to help facilitate the creation of OION, the Trust’s move to Mill Street, the spinout of Oxford Innovation and now the move to Stansfield Park. I hope I can make a contribution in the future.
The work of the Trust is a key to our future prosperity.”